# Clustering Approach 3 : CN_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.00014406576065995	Range of duration = 0.03 to 187.07, nDeath = 41, nCensor = 397
2	AGE	ANOVA	5.70262061449394e-10	Range of values = 31 to 90, Mean = 63.5362, StdDev = 11.2423, nMissing = 1
3	HISTOLOGICAL.TYPE	Chi-square test	2.0720615470951e-35	nTypes = 7 (ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1 OR 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 1)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 2)/ENDOMETRIOID ENDOMETRIAL ADENOCARCINOMA (GRADE 3)/MIXED SEROUS AND ENDOMETRIOID/SEROUS ENDOMETRIAL ADENOCARCINOMA), nPatients = 327/3/8/2/7/18/78
4	RADIATIONS.RADIATION.REGIMENINDICATION	Chi-square test	0.098290882770496	nTypes = 2 (NO/YES), nPatients = 133/310
5	NEOADJUVANT.THERAPY	Chi-square test	0.0449711196169884	nTypes = 2 (NO/YES), nPatients = 105/338